Home > Boards > US Listed > Biotechs > Avita Medical Ltd. (RCEL)

I have this nagging fear of dilution

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Longoo Member Profile
 
Followed By 0
Posts 15
Boards Moderated 0
Alias Born 10/10/19
160x600 placeholder
AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food & Drug Administrati... Business Wire - 6/1/2020 9:28:00 PM
AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference Business Wire - 5/21/2020 4:01:00 PM
AVITA Medical to Participate at Oppenheimer's MedTech Summit Business Wire - 5/13/2020 4:01:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/12/2020 11:00:49 AM
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC &... Business Wire - 5/11/2020 4:31:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/11/2020 12:22:49 PM
AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convenin... Business Wire - 5/11/2020 11:47:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/29/2020 2:14:54 PM
AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update Business Wire - 4/29/2020 1:10:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/20/2020 5:25:55 PM
AVITA Medical Announces Intention to Redomicile to the United States of America Business Wire - 4/20/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/15/2020 6:01:04 AM
AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update Business Wire - 4/6/2020 8:00:00 AM
RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online Business Wire - 4/1/2020 8:35:00 PM
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL® System for Pediatric Scald Injuries Business Wire - 3/4/2020 4:01:00 PM
AVITA Medical to Attend the 2020 BTIG Healthcare Conference Business Wire - 3/3/2020 4:05:00 PM
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction Business Wire - 3/2/2020 10:21:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/19/2020 4:28:21 PM
AVITA Medical Half-Year Financial Report for Fiscal 2020 Business Wire - 2/19/2020 1:04:00 AM
AVITA Medical to Present at the Cowen 40th Annual Health Care Conference Business Wire - 2/11/2020 4:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/3/2020 12:28:14 PM
AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update Business Wire - 1/30/2020 7:38:00 PM
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL Sy... Business Wire - 12/29/2019 6:49:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/6/2019 6:02:01 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2019 4:39:02 PM
Longoo   Wednesday, 04/29/20 09:02:21 AM
Re: Spetch post# 5673
Post # of 5729 
I have this nagging fear of dilution soon after the move to the US when total float is reduced to approx +- 20 million shares. That seems like a low float at a high multiple that could restrict/constrain liquidity (especially on management compensation shares?).
More of a question than a thesis if anyone could help me think through this.
(tdeck. jugs, melody, J Samuel, others with a better understanding)?
I have been a long term holder since 2013 and remain VERY optimistic on the product and it's potentials. Only fear management and dilution.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist